NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

pgsd,

" It is interesting and promising showing the future of trials, also of interest, of a total of 47 patients in the phase 2b trial the most common AEs patients experienced during the treatment period and follow-up included 20 patients with seizure (42.6%)" .

They are still in phase 2b.
They have yet to start phase 3.
And then of course 5 years! PFS is no longer a benchmark, everyone has to start comparing it to the 5 year survival with DCvax.
Also, for example, 3-year survival figures from other parties cannot be compared with anything, it concerns the survivors (5 years and even longer).
Meanwhile, NWBO has all the time and possibilities to improve these (NWBO'S) survival times as well.
It seems to me a hopeless case for other parties. They are at least 5 years behind.
imo.

GLTU